These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 105227)

  • 21. [Acute granulous leukemia in multiple myeloma. Apropos of 5 cases].
    Krulik M; Grolleau JY; Audebert AA; Mougeot-Martin M; Harousseau JL; Hervouet D; Debray J
    Sem Hop; 1977 Dec; 53(42):2425-35. PubMed ID: 203043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute myeloid leukemia following treatment of Hodgkin's disease: a review.
    Grünwald HW; Rosner F
    Cancer; 1982 Aug; 50(4):676-83. PubMed ID: 6953991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature.
    Rosner F; Grünwald H
    Am J Med; 1975 Mar; 58(3):339-53. PubMed ID: 1090158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alkylating agents as leukemogens in multiple myeloma.
    Karchmer RK; Amare M; Larsen WE; Mallouk AG; Caldwell GG
    Cancer; 1974 Apr; 33(4):1103-7. PubMed ID: 4522494
    [No Abstract]   [Full Text] [Related]  

  • 26. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.
    Cimino G; Papa G; Tura S; Mazza P; Rossi Ferrini PL; Bosi A; Amadori S; Lo Coco F; D'Arcangelo E; Giannarelli D
    J Clin Oncol; 1991 Mar; 9(3):432-7. PubMed ID: 1999712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute leukemia as a complication of cytotoxic chemotherapy.
    Rosner F; Grünwald HW; Zarrabi MH
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1705-7. PubMed ID: 536280
    [No Abstract]   [Full Text] [Related]  

  • 28. Leukemia after chemotherapy of Hodgkin's disease.
    Castro GA; Church A; Pechet L; Snyder LM
    N Engl J Med; 1973 Jul; 289(2):103-4. PubMed ID: 4513796
    [No Abstract]   [Full Text] [Related]  

  • 29. Adrenal steroids in the treatment of malignant hematologic disease.
    Cline MJ
    Med Clin North Am; 1973 Sep; 57(5):1203-9. PubMed ID: 4205834
    [No Abstract]   [Full Text] [Related]  

  • 30. [Induced malignant hemopathies. 6 new cases with 1 patient surviving 45 months].
    Clément F
    Schweiz Med Wochenschr; 1979 Apr; 109(15):544-51. PubMed ID: 286415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
    Tura S; Fiacchini M; Zinzani PL; Brusamolino E; Gobbi PG
    J Clin Oncol; 1993 May; 11(5):925-30. PubMed ID: 8487056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte mean corpuscular volume during cytotoxic therapy and the risk of secondary leukemia.
    de Gramont A; Rioux E; Drolet Y; Delage JM
    Cancer; 1985 Feb; 55(3):493-5. PubMed ID: 4038378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Granulocytic sarcoma in acute non-lymphoblastic leukemia as the terminal phase of multiple myeloma under prolonged treatment with alkylating agents].
    Bernardeschi P; Urbano U
    Haematologica; 1983; 68(5):684-8. PubMed ID: 6416948
    [No Abstract]   [Full Text] [Related]  

  • 34. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
    Travis LB; Weeks J; Curtis RE; Chaffey JT; Stovall M; Banks PM; Boice JD
    J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The action of antitumor agents: a double-edged sword?
    Sieber SM
    Med Pediatr Oncol; 1977; 3(2):123-31. PubMed ID: 327250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.
    Greene MH; Boice JD; Greer BE; Blessing JA; Dembo AJ
    N Engl J Med; 1982 Dec; 307(23):1416-21. PubMed ID: 6752720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute leukaemia in patients treated for Hodgkin's disease.
    Papa G; Mauro FR; Anselmo AP; Cimino G; Alimena G; Amadori S; D'Arcangelo E; Giannarelli D; Bosi A; Bellesi G
    Br J Haematol; 1984 Sep; 58(1):43-52. PubMed ID: 6466571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
    Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
    Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents.
    Sotrel G; Jafari K; Lash AF; Stepto RC
    Obstet Gynecol; 1976 Jan; 47(1):67S-71S. PubMed ID: 1061006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal sensitivity of lymphocytes from individuals with therapy-related acute nonlymphocytic leukemia.
    Schwartz JL; Karrison T; Le Beau MM; Larson RA; Sagher D; Strauss B; Rowley JD; Weichselbaum RR
    Mutat Res; 1989 Apr; 216(2):119-26. PubMed ID: 2494444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.